In relation to cancers, NAT10 reportedly promotes tumor progression in hepatocellular carcinoma, breast cancer, gastric cancer, head, and neck squamous cell carcinoma, and bladder cancer [8, 12, 24, 53, 54]. Here, NAT10 is linked to urinary bladder carcinoma.